Unitree just put a public price on a humanoid maker — about $9 billion, and a fraction of the private hype.

Unitree priced its Shanghai STAR Market initial public offering on August 6 at 150.8 yuan — about $22.34 — a share, valuing the Hangzhou company at around 61 billion yuan, or roughly $9.04 billion. The maker, also registered as Yushu Technology, is selling 40.45 million new shares, or 10% of its enlarged share capital, to raise about 6.1 billion yuan (near $900 million), with subscriptions opening August 10 and trading expected later in the month. The final valuation came in above an earlier target of up to 50 billion yuan that Reuters had reported, and it makes Unitree the first pure-play humanoid robotics company to list on mainland China's markets — Hong Kong-listed UBTech went public back in 2023 — which matters beyond the flag-planting: it is the first time investors get a real, regulator-approved, market-set price for a profitable humanoid maker rather than a privately negotiated round.

That public number is the story, because it is far smaller than the private marks floating around the sector. Unitree's own prospectus shows revenue more than quadrupled to 1.7 billion yuan in 2025, with humanoid robots generating 867.8 million yuan and overtaking the company's famous robot dogs as its largest business for the first time. But the growth is decelerating and profitability is thin: first-quarter 2026 revenue rose 68.5% to 422.8 million yuan, yet profit excluding one-off items fell 52.6% to 40.3 million yuan as Unitree poured money into research and marketing. A roughly $9 billion price tag on a company with about $235 million of 2025 revenue is already aggressive — and it sits well below Figure's reported $39 billion private valuation and analysts' multi-tens-of-billions estimates for Tesla's yet-to-ship Optimus business. The first market-tested humanoid valuation, in other words, is a fraction of what private investors have been paying on narrative alone.

The timing sharpens everything. Chinese AI company DeepSeek came in as a strategic investor — a notable software-side endorsement for a hardware maker whose robots increasingly run large-model AI — but the listing lands just over a week after the U.S. Federal Communications Commission added foreign-made humanoids and quadrupeds to its Covered List on July 28, blocking new foreign models from the equipment authorization they need to be sold in the United States. Unitree, which sells some of the cheapest humanoids on the market and ships them in higher volume than any Western rival, is arguably the maker with the most to lose: its prospectus discloses that the U.S. accounted for 13.3% of 2025 revenue and warns that tariffs, government-purchase limits, export controls or the loss of existing approvals could hurt overseas growth. The company's position is that its already-authorized humanoid and quadruped models keep their U.S. clearance, while future models could be barred.

For a buyer, the IPO changes the financing picture, not the shopping list. Unitree remains the volume-and-price leader in humanoids, but the listing does not create a new U.S. import path, and the FCC action is the operative fact for any American procurement team: existing authorized Unitree units can still be bought, while new models are now blocked pending a conditional-approval route. The more useful development is transparency. Because Unitree will now file public financials, buyers and rivals finally get an audited-style window into what a high-volume humanoid business actually earns — the gross margins, the cost of scaling, whether shipping thousands of robots turns into durable profit. Watch the post-listing disclosures more than the first-day pop: the number that matters is whether unit economics hold up once the robots have to answer to a quarterly report.